New for 2018!
North America and the US are leading the charge when it comes to innovations in biopharmaceuticals. So it stands to reason that CPhI North America serves as a global platform for converging small and large molecule markets by offering a one-stop-pharma-shop for companies to source for their requirements on manufacturing and processing. With 50% of surveyed 2017 buyers onsite looking to meet new suppliers in the Bio-sphere, CPhI North America 2018 is your time to establish your presence in the North American market.
Biopharmaceuticals currently generate global revenues of $162 billion.
The Biopharmaceutical market is projected to grow at CAGR 9.4% in 2017-2021, reaching $278 billion by 2021.
Biomanufacturers will be spending more on innovation, increasing their budgets an expected 6% for new technologies.
Outsourcing of biopharmaceutical manufacturing will continue to increase as companies aim to increase testing services and production efficiencies.
Bringing You the Future of Biopharma
Breakfast Session: Accepting the Challenge
Over the last two decades, the development of immuno-oncology and next-generation cell-based therapeutics has truly revolutionized the Biologics Industry. In parallel with these advancements, a growing number of companies have also focused on rare diseases and biosimilars drug development, thereby further taxing an already constrained manufacturing Supply Chain. Given the clear shortage of skilled labor and manufacturing resources, we submit that industry can no longer afford to manage these constraints independently, and therefore must actively partner with a globally recognized Institution such as NIBRT (National Institute for Bioprocessing Research and Training) to provide world class training for professionals and students who are pursuing a career in the Biologics Manufacturing Industry. Furthermore, the inherent complexities of Biologics manufacturing mandates training programs that will support risk reduction, improve quality and efficiencies, and create innovative solutions throughout the Supply Chain. Over the past three years, highlighted in every industry forum, the feedback we have received has noted a lack a skilled workforce as our number one risk factor. The discovery of life-changing drugs is no longer our sole challenge - equally important is preserving and growing the skilled talent pool that enables the manufacturing of such innovative medicines.
Please join us to talk about how we are reducing this risk in North America with the newly created NIBRT and Jefferson Institute for Bioprocessing Partnership. Dr. Ron Kander, Dean, Kanbar College of Design, Engineering and Commerce and Associate Provost for Applied Research, Jefferson University will talk about the future of the Institute and how you and your company can become involved. Breakfast by invitation only.
bioLIVE is a new focused event with an exhibition and a live content stage, focusing on large molecule Biopharma and more specifically on manufacturing and processing. To learn more about bioLIVE and how you can get involved. go here.
CPhI North America 2017 at a Glance
We know that professionals in bio prefer events where they can meet other biopharma companies— from universities with renowned R&D programs to big pharma’s biologic and biosimilars to regulators. So we specifically-created the new-for-2018 Bioprocessing Zone to give biopharma professionals a space to meet all the people, companies, and suppliers to conquer some of their biggest challenges.
Do Business Better
CPhI North America offers you a unique platform to meet your peers, clients and prospects face-to-face. Don’t miss the chance to connect with a qualified group of relevant buyers looking for new products, suppliers and services.
- 80% of attendees have a role in the purchasing cycle
- 68 % of attendees said they were likely to do business with one or more exhibiting company
- 48% of attendees were new to CPhI events
Attendees visit the show with a singular focus: to find the latest innovations in machinery, equipment, and technology.
“It was wonderful. Well organized, great range of companies represented. My company and I made a lot of promising connections”
- Marketing / Communications / PR, Other: Multi disciplines-BioTech, Pharmaceutical, USA
It is the best opportunity for the members in global pharmaceutical market regarding find a new strategy and build up the new idea in all the value-chain.
- Sales, Pharmaceutical Company (generic finished products), South Korea
2017 Attendees Included...
Associate Director, Scientific Affairs - Sandoz
Associate Director, Strategic Sourcing – Novartis
Biochemist - Siemens
Buyer - Adesis, Inc
Category Manager Global Procurement - Bristol Myers Squibb
Director, CMO Business - Sanofi
Director, Global Procurement - Pfizer
Director, Procurement - MilliporeSigma
Director, Procurement & Supplier Quality – Fujifilm
Director, Purchasing & Supplier Management – AbbVie
Director, Research - Baxter Healthcare
Director, Science & Technology - Catalent
Global Category Buyer - BASF
Global Category Leader - GSK
Head, Topical Formulation and Process Development - GSK
Manager, Facility & Procurement - Adesis, Inc
Manager, Strategic Sourcing - Johnson & Johnson
R&D Procurement - Johnson & Johnson
Research Scientist - Bayer
Senior Formulation Scientist - GSK
Senior Scientist - Bristol Myers Squibb
Senior Scientist - GSK
Senior Sourcing Manager - Bristol Myers Squibb
Sourcing Manager - Sanofi
Vice President, R&D Technology - Johnson & Johnson
Products & Services Found in the Bioprocessing Zone
Academia and Research Centres | Analytical Chemistry | Analytical Methods | Antibodies | Bio Clusters | Bio process technologies | Bioelectronics | Bioinformatics | Biopharmaceuticals | Biotechnology and related specialities | Bio-similar | Cell biology | Diagnostics | Genomics & Proteomics | Immunology | Medicinal chemistry | Molecular Biology | Platform technologies | Process validation | Protein chemistry | Technology and software | Tissue Culture Medias | Toxicology / virology